Beau Webber, PhD

Assistant Professor, Department of Pediatrics

Beau Webber

Contact Info

webb0178@umn.edu

Office Phone 612-626-2778

Fax 612-626-2815

Office Address:
2231 6th St Se., Room 2-146
Minneapolis, MN 55455

Lab Address:
2231 6th St Se., Room 2-230B45
Minneapolis, MN 55455

Postdoctoral Fellowship in Pediatric Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN

PhD, Molecular, Cellular, Developmental Biology, and Genetics, University of Minnesota Medical School, Minneapolis, MN

BS, Biology, Cellular and Molecular Emphasis, University of Wisconsin, La Crosse, WI

Summary

Dr. Beau Webber is an Assistant Professor in the Department of Pediatrics, Division of Hematology and Oncology at the University of Minnesota. He graduated from the University of Wisconsin- LaCrosse in 2007 with a BS in Cellular and Molecular Biology and conducted his Ph.D. studies at the University of Minnesota where he studied the embryonic development of hematopoietic stem cells. As a postdoctoral fellow in the Hematology, Oncology, and Transplantation program at the University of Minnesota, Dr. Webber developed advanced strategies for genetic modification of human lymphohematopoietic and pluripotent stem cells for cancer immunotherapy and correction of inherited diseases. Dr. Webber joined the Department of Pediatrics Faculty as an Assistant Professor in 2017. 

Awards & Recognition

  • Children’s Cancer Research Fund (CCRF) Emerging Scientist Award (2017)
  • Young Investigator Award, Alex's Lemonade Stand Foundation on behalf of Northwestern Mutual Foundation (2017)
  • Abstract Achievement Award, Annual Meeting of the American Society of Hematology (2011)
  • Outstanding Senior of the Year in Cellular and Molecular Biology (2007)

Research

Research Summary/Interests

Dr. Webber’s laboratory is focused on synergizing genome engineering, stem cell biology, and adoptive cellular therapy to develop novel treatments for genetic disease and cancer. Research projects in the lab currently fall into two broad areas: the application of genome engineering to develop improved cell-based immune and gene therapies, and the development of “bottom-up” cancer models using human pluripotent stem cells.